Celldex Therapeutics Inc (CLDX)
39.91
-1.15
(-2.80%)
USD |
NASDAQ |
May 10, 16:00
39.91
0.00 (0.00%)
After-Hours: 20:00
Celldex Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2013 | 3.31% |
December 31, 2012 | 2.63% |
September 30, 2012 | 3.44% |
June 30, 2012 | 6.77% |
March 31, 2012 | 3.66% |
December 31, 2011 | -274.7% |
September 30, 2011 | |
June 30, 2011 | 0.56% |
March 31, 2011 | 0.56% |
December 31, 2010 | 81.97% |
September 30, 2010 | 49.42% |
June 30, 2010 | 41.31% |
March 31, 2010 | 37.33% |
December 31, 2009 | 42.36% |
September 30, 2009 | 48.59% |
June 30, 2009 | 49.01% |
March 31, 2009 | 40.25% |
December 31, 2008 | |
September 30, 2008 | |
June 30, 2008 | |
March 31, 2008 | |
December 31, 2007 | |
September 30, 2007 | |
June 30, 2007 | |
March 31, 2007 |
Date | Value |
---|---|
December 31, 2006 | |
September 30, 2006 | |
June 30, 2006 | |
March 31, 2006 | -17.33% |
December 31, 2005 | |
September 30, 2005 | |
June 30, 2005 | |
March 31, 2005 | -315.3% |
December 31, 2004 | |
September 30, 2004 | |
June 30, 2004 | |
March 31, 2004 | |
December 31, 2003 | |
September 30, 2003 | |
June 30, 2003 | |
March 31, 2003 | |
December 31, 2002 | |
September 30, 2002 | 99.77% |
June 30, 2002 | 97.36% |
March 31, 2002 | 98.02% |
December 31, 2001 | 98.92% |
September 30, 2001 | 98.84% |
June 30, 2001 | 99.01% |
March 31, 2001 | |
December 31, 2000 |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
ThermoGenesis Holdings Inc | -1.58% |
Perspective Therapeutics Inc | -- |
Electromed Inc | 77.03% |
Xtant Medical Holdings Inc | 60.97% |
Asensus Surgical Inc | 21.47% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -34.58% |
Return on Assets | -32.36% |
Return on Invested Capital | -34.58% |
Profit Margin (Quarterly) | -21.03K% |
Operating Margin (Quarterly) | -26.03K% |
Return on Net Operating Assets | -407.8% |